GSK Plc (GSK)
48.56
+0.15
(+0.31%)
USD |
NYSE |
Dec 08, 15:29
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 97.58B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 46.19% |
| Valuation | |
| PE Ratio | 13.85 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.380 |
| Price to Book Value | 4.489 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.4171 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 1.099 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 39.39% |
Profile
| GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom. |
| URL | http://www.gsk.com |
| Investor Relations URL | https://www.gsk.com/en-gb/investors/ |
| HQ State/Province | Greater London |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 04, 2026 |
| Last Earnings Release | Oct. 29, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 14, 2025 |
Ratings
Profile
| GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom. |
| URL | http://www.gsk.com |
| Investor Relations URL | https://www.gsk.com/en-gb/investors/ |
| HQ State/Province | Greater London |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 04, 2026 |
| Last Earnings Release | Oct. 29, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 14, 2025 |